MedTrace Logo

Ginsenoside Improve Metabolic Syndrome

NCT02034136 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-01-13

No results posted yet for this study

Summary

Aim : Investigated the effects of Korean red ginseng supplementation on metabolic parameters such as cholesterol, blood pressure and glucose.

Randomized Control Trial.

Conditions

  • Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

Ginsenoside

3.0 g/ d for 28 days

DIETARY_SUPPLEMENT

Dietary fiber fill

3g/day, 28days

Sponsors & Collaborators

  • The Korean Society of Ginseng

    collaborator OTHER

  • CHA University

    lead OTHER

Principal Investigators

  • DH Jung, MPH.M.D. · Cha Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-09-30
Completion
2014-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02034136 on ClinicalTrials.gov